key: cord-0791497-7zvjsafm
authors: Iijima, Hiroyuki; Funaki, Takanori; Kubota, Mitsuru
title: Clinical features and outcomes of coronavirus disease 2019 in early infants in Japan: A case series and literature review
date: 2022-01-06
journal: J Infect Chemother
DOI: 10.1016/j.jiac.2021.12.026
sha: 85dfff5f3f33418af78452903e18d789de7e6ca9
doc_id: 791497
cord_uid: 7zvjsafm

The clinical picture in early infants with COVID-19 has been described in a limited number of reports, mainly from European countries, United States, and China, but not Japan. Although several reports suggested that early infants can develop more severe COVID-19 disease than older children, risk factors for severe illness and differences according to nationality or ethnicity remain unclear. We report a case series of 13 infants ≤90 days old with COVID-19 in Japan. All patients had mild outcomes and did not require respiratory support or intensive care.

was confirmed by positivity in a reverse transcriptase polymerase chain reaction (RT-PCR) for SARS-CoV-2 in nasopharyngeal swabs. We collected demographic and clinical characteristics, medical history, laboratory data, and radiological findings from the electronic medical records.

We classified the patients according to the severity based on the guidelines from the World Health Organization [6] . Categorical variables were expressed as numbers of cases and percentage, and continuous variables were expressed as the mean/median with IQR/range. Informed consent was obtained from all the patient's parents with opt-out possibility. This study was approved by the Ethics Committees of the National Center for Child Health and Development in September 2021 (#2021-129).

Between July 2020 and August 2021, 226 children with COVID-19 were hospitalized in our hospital. Among these patients, we identified 13 infants (5.8%) younger than 90 days.

Clinical characteristics, laboratory data, and imaging findings are summarized in Table 1 . The mean age at presentation was 52 days (range 16-86 days). Male infants represented 38% of the patients. Most of the patients were Japanese. All 13 patients had household contact with confirmed COVID-19 patients, and about half of them received diagnoses of COVID-19 during contact tracing. There was no history suggestive of vertical infection, such as episodes of maternal infection or onset of disease in patients less than 14 days old. Three (23%) patients had comorbidities as follows: a preterm infant at 34 weeks of gestation (n=1), small ventricular septal defect (1 mm in diameter) (n=1), and feeding disorder requiring nasogastric tube feeding J o u r n a l P r e -p r o o f (n=1). The frequent symptoms were rhinorrhea (69%), fever (62%), cough (54%), poor feeding (54%), and cold extremities (31%). The median duration of fever (≥38.0 °C) and maximum temperature was 1 day (range: 0-2 days) and 38.1 °C (range: 37.2 °C-39.6 °C), respectively. Two (15%) presented with vomiting, but no one had diarrhea. No patients had respiratory distress, apnea, hypoxia, seizure, or conjunctivitis. One patient had no symptoms during the disease course. Blood examinations on admission were performed in 9 of 13 patients, with a median duration of 2 days after onset (range: 1-5 days). Median value of C-reactive protein was 0.02 mg/dL (range: 0.01-0.42 mg/dL). Aspartate aminotransferase, alanine aminotransferase, creatine kinase, and lactate dehydrogenase levels were normal, except for one preterm patient with a mildly elevated aspartate aminotransferase of 79 U/L and lactate dehydrogenase of 416 U/L. The patient had rhinorrhea, cough, and poor oral feeding, but no fever. No patients presented with leukocytosis, lymphocytosis, or lymphocytopenia. Two patients showed neutropenia (0.47×10 9 /L and 0.74×10 9 /L). Blood and urine cultures were performed in 7/13 (54%) and 5/13 (38%) patients, respectively, with negative results in all the patients. Among them, empirical antibiotics were administered in two patients. The remaining 6 patients without blood cultures did not receive any antibiotics. Finally, no patients had bacterial coinfections detected. Among 7 patients who underwent chest X-ray, 4 (54%) had pulmonary infiltrates. No We summarized case series and reviews reporting early infants with COVID-19 (Table   2 ). Most patients were mildly ill, but one systematic review included many patients that required ICU admission and respiratory support. Severe cases were characterized by co-infection (urinary tract infection or respiratory syncytial virus infection), congenital heart disease, immunodeficiency, preterm birth, or MIS-C.

This study reports clinical characteristics of COVID-19 in infants less than 90 days old in Japan. All 13 patients had mild outcomes and did not require respiratory support or intensive care. Thus far, only a few case series of early infants with COVID-19 have been available, and risk factors for severity remain unclear. A case series from Saudi Arabia suggested that infants ≤90 days old can develop more severe COVID-19 disease than older children [4] .

Early infants with severe COVID-19 described in this review included those with severe pre-existing medical conditions (cyanotic heart disease, immunodeficiency, or extreme prematurity), MIS-C, or co-infection [3] [4] 9] . Our cases did not involve severe comorbidities or MIS-C. There was one patient with premature birth and one patient with congenital heart disease, both of whom had a mild course of COVID-19. This outcome may be because the J o u r n a l P r e -p r o o f 7 degree was mild in the 34-week birth and small ventricular septal defect cases, respectively. So far, the four rhinovirus/enterovirus co-infection patients reported, including ours, all had favorable outcomes. It is still unclear whether co-infection with any virus is more likely to cause severe disease because of the small number of cases in which multiplex PCR was performed in both our study and previous studies. These data suggest that a major risk factor for early infants can be a severe pre-existing medical condition, such as cyanotic heart disease or immunodeficiency.

Other case series with similar conditions to our study also showed a mild clinical course of COVID-19 except for one case with bacterial co-infection [5, 9] . In contrast, the systematic reviews have shown that early infants with COVID-19 require more intensive care and respiratory support than older children [3, 8, 10] . This difference in severity may be due to the younger age of the patients in the review and the inclusion of more case reports that are prone to publication bias. As the case series summarized here does not include early neonates or cases of vertical infection, it may be necessary to consider early neonates as a separate group among early infants younger than 90 days.

Our results showed that respiratory symptoms were more prevalent than gastrointestinal symptoms. This finding is consistent with previous case series, including asymptomatic patients [5] . Although one case series reported patients ≤90 days had a predominance of gastrointestinal syndromes (13/14, 93% of patients), this study included only symptomatic cases, and might The main laboratory findings in our study, including mild elevation of aminotransferase values and neutropenia, are consistent with previous reports [3, 9] . We also found that more than half of the patients who had chest X-rays had pulmonary infiltrates despite their mild clinical course. This result suggested that a chest X-ray might not help determine the severity of COVID-19 in early infants.

Differences in children with COVID-19 according to nationality or ethnicity have not been adequately examined, with only a case series of an over-representation of Latinx ethnicity [5] . A systematic review of mostly Chinese children found that neonates and children under one year were more vulnerable to more severe COVID-19 disease than older children [12] . By contrast, there were no severe cases in our Japanese patients. Further studies are needed to determine whether Asians are more susceptible to severe disease. This study is limited by the small number of cases from a single center and the retrospective observational study design.

Due to the bias in the patients' nationality, this case series might not be generalizable to other populations. However, to our knowledge, this is the first Japanese case series, which contributes to the accumulation of data on diverse populations.

In conclusion, we described 13 patients less than 90 days old with COVID-19. Half of them were identified during contact tracing. All had a mild clinical course and respiratory symptoms predominated over gastrointestinal symptoms. Enterobacter cloacae (n = 1)

Escherichia coli (n = 2)

COVID-19) Dashboard. World Health Organization web site

COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study

Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Young Infants: A Systematic Review

Disease in Infants Less Than 90 Days: Case Series

SARS-CoV-2 Infection in Infants Less than 90 Days Old

Clinical management of COVID-19: interim guidance. World Health Organization web site

Clinical analysis of 10 neonates CRP (mg/dL)

All authors do not have any potential, perceived, or real conflicts of interest.J o u r n a l P r e -p r o o f